Related Experiment Video
Updated: Dec 26, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Breaking Down the Barriers to Define and Treat NK/T Cell Lymphoma
Bethany Mundy-Bosse1, David M Weinstock2
1Division of Hematology, Department of Internal Medicine, Ohio State University, Columbus, OH 43210, USA.
Abstract:
In this issue of Cancer Cell, Xiong and colleagues describe the genomic and transcriptional landscape of natural killer/T cell lymphoma (NKTCL), a rare form of non-Hodgkin's lymphoma associated with EBV infection. They divide NKTCL into molecularly defined subtypes that could inform therapeutic strategies for patients with this deadly disease.
Insights
Researchers mapped the genomic and transcriptional features of natural killer/T cell lymphoma (NKTCL), an EBV-associated non-Hodgkin's lymphoma. Identifying molecular subtypes of NKTCL offers new therapeutic avenues for this aggressive cancer.
Area of Science:
- Oncology
- Genomics
- Immunology
Background:
- Natural killer/T cell lymphoma (NKTCL) is a rare, aggressive non-Hodgkin's lymphoma.
- NKTCL is strongly associated with Epstein-Barr virus (EBV) infection.
- Limited understanding of NKTCL molecular heterogeneity hinders effective treatment.
Purpose of the Study:
- To comprehensively characterize the genomic and transcriptional landscape of NKTCL.
- To identify distinct molecular subtypes within NKTCL.
- To provide a foundation for developing targeted therapeutic strategies.
Main Methods:
- Whole-genome sequencing and RNA sequencing were employed.
- Analysis focused on identifying key genetic alterations and gene expression patterns.
- Integration of genomic and transcriptomic data to define molecular subtypes.
Main Results:
- Detailed genomic profiles of NKTCL tumors were elucidated.
- Distinct transcriptional signatures corresponding to molecular subtypes were identified.
- Specific driver mutations and dysregulated pathways were highlighted.
Conclusions:
- NKTCL can be classified into molecularly defined subtypes based on genomic and transcriptional data.
- These subtypes represent distinct biological entities with potential therapeutic implications.
- This molecular subtyping advances understanding and treatment strategies for NKTCL patients.
More Related Videos
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Related Concept Videos
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...